Eramet S.a.
ERMAF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $3 | $2 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $3 | $3 | $4 | $3 |
| Revenue | $1 | $1 | $1 | $2 |
| % Growth | -4.3% | -3.3% | -9.5% | – |
| Gross Profit | $1 | $1 | $1 | $0 |
| % Margin | 65.1% | 52.5% | 64.2% | 5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 1.5% | 16% | 2% | 10.7% |
| Net Income | -$0 | $0 | -$0 | $0 |
| % Margin | -11% | 3.8% | -2.7% | 0.7% |
| EPS Diluted | -5.31 | 1.93 | -1.44 | 0.37 |
| % Growth | -375.1% | 234% | -489.2% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |